All In MedTech

FDA Clearance Tracker · P000058-S095

INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 26, 2026

Approved

Time to decision

530 days

Received Mar 14, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000058-S095
Device name
INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE
Applicant location
Memphis, TN
Received
Mar 14, 2025
Decided
Aug 26, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000058

Device type

Device class
Class III

Every decision under product code NEK

FDA's approval statement

As written in FDA's record.

Approval for a change to the potency testing of rhBMP-2 used in the manufacturing of INFUSE Bone Graft.

Source documents

Other decisions for Medtronic Sofamor Danek USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.